This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "osteoarthritis_cartilage_degradation#Matrix-Degrading Enzyme Upregulation"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding chondrocyte cell type, biological processes, and causal edges, specialized to their context. Key substitutions: post-traumatic OA substitutes a discrete joint-injury trigger (ligament/meniscal injury) for the chronic-overload trigger; genetic OA (e.g., type II collagenopathies, ACAN/aggrecan defects) substitutes the primary ECM/structural lesion upstream of chondrocyte stress while preserving the downstream matrix-degradation chain.
Mechanical Overload and Chondrocyte Stress
trigger
Abnormal mechanical loading or acute joint injury imposes excessive stress on articular chondrocytes, the sole resident cell of cartilage. Across primary/idiopathic, post-traumatic, and genetic OA the initiating insult varies (chronic malalignment or obesity-related overload, discrete ligament/meniscal trauma, or an intrinsic ECM/structural weakness), but the response converges on a chondrocyte stress program that initiates the catabolic cascade and primes the cell for apoptosis and matrix degradation.
Downstream
-
Catabolic Chondrocyte Phenotype and Cytokine Signaling
Show evidence (2 references)
"This review highlights the molecular mechanisms of mechanical loading in inducing chondrocyte apoptosis and extracellular matrix degradation."
Establishes mechanical loading as the initiating insult that drives chondrocyte stress/apoptosis and downstream matrix degradation. Evidence source is OTHER because this is a review synthesizing multiple study types.
"Abnormal mechanical loading activates the interleukin-1β, tumour necrosis factor-α, nuclear factor kappa-B, Wnt, transforming growth factor-β, microRNAs pathways, and the oxidative stress pathway."
Links the mechanical trigger to the proinflammatory cytokine signaling (IL-1beta, TNF-alpha, NF-kB) that defines the downstream amplifier node. Evidence source is OTHER because this is a review.
Catabolic Chondrocyte Phenotype and Cytokine Signaling
amplifier
Stressed chondrocytes shift from a quiescent matrix-maintaining phenotype to a catabolic, hypertrophic-like state. Proinflammatory cytokines, principally IL-1beta and TNF, are produced within the joint (by chondrocytes and by synovial macrophages) and act in autocrine and paracrine loops to sustain a low-grade inflammatory environment. This cytokine signaling reprograms chondrocyte gene expression toward catabolism, suppressing anabolic matrix synthesis and inducing the matrix-degrading enzymes that execute cartilage breakdown.
Downstream
-
Matrix-Degrading Enzyme Upregulation
Show evidence (3 references)
"OA is now well accepted as a low-grade inflammatory disease affecting the whole joint."
Establishes the low-grade inflammatory state of the joint as a core feature of OA. Evidence source is OTHER because this is a review article.
"paracrine interactions between macrophages and chondrocytes play a vital role in the initiation and development of OA by secreting inflammatory cytokines, growth factors, matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs), which lead to subsequent cartilage..."
Directly links cytokine and MMP secretion in the joint to subsequent cartilage degradation, bridging the inflammatory amplifier to the enzyme-upregulation effector. Evidence source is OTHER (review).
"IPA significantly inhibited the IL-1β-induced expression of inflammatory factors (Nitric oxide, PGE2, TNF-α, IL-6, iNOS and COX-2) and matrix-degrading enzymes (MMP-3, MMP-13 and ADAMTS-5)"
Cell-based data show that IL-1beta induces both inflammatory mediators and the matrix-degrading enzymes MMP-13 and ADAMTS-5 in chondrocytes, demonstrating the cytokine-to-catabolism link of this node.
Matrix-Degrading Enzyme Upregulation
central effector
Catabolic chondrocyte signaling upregulates the key matrix-degrading enzymes of OA: the collagenase MMP-13, which cleaves the type II collagen fibrillar network, and the aggrecanase ADAMTS-5, which cleaves aggrecan. Aggrecan loss is an early event that exposes the collagen network to enzymatic and mechanical attack; collagen degradation that follows is essentially irreversible. This proteolytic step is the central effector that converts chondrocyte catabolism into structural matrix destruction.
Downstream
-
Cartilage Matrix Loss and Subchondral Bone Remodeling
Show evidence (2 references)
"Studies on transgenic mice have confirmed the central role of Adamalysin with Thrombospondin Motifs 5 (ADAMTS-5) in aggrecan degradation, and the collagenolytic matrix metalloproteinase MMP-13 in collagen degradation."
Identifies ADAMTS-5 and MMP-13 as the central enzymes degrading aggrecan and type II collagen, the defining effectors of this node. Evidence source is OTHER because this is a review article.
"An important manifestation of OA is the enhanced production of matrix-degrading enzymes matrix metalloproteinase-13 (MMP-13)"
States that enhanced production of MMP-13 is a key manifestation of OA, supporting the enzyme-upregulation effector. Evidence source is OTHER because this is the introductory review portion of the article.
Cartilage Matrix Loss and Subchondral Bone Remodeling
effector
Sustained proteolysis produces progressive loss of the cartilage matrix as aggrecan and collagen are depleted faster than they can be replaced. Loss of the load-bearing matrix alters joint mechanics and couples to the subchondral bone, which undergoes increased turnover, plate sclerosis, and osteophyte (new bone and cartilage) formation at the joint margins. These cartilage and bone changes are mechanically and biochemically coupled and together remodel the whole-joint architecture.
Downstream
-
Joint Cartilage Degradation with Pain and Functional Impairment
Show evidence (3 references)
"OA is the outcome of the progressive loss of aggrecan from cartilage, which results in both exposure of the collagen matrix and its disintegration by metalloproteases."
Describes progressive aggrecan loss and consequent collagen matrix disintegration as the structural outcome of the proteolytic effector. Evidence source is OTHER (introductory review portion of the article).
"Ample evidence has been found for bone changes during progression of OA including, but not limited to, increased turnover in the subchondral bone, undermineralisation of the trabecular structure, osteophyte formation, bone marrow lesions and sclerosis of the subchondral plate."
Directly documents subchondral bone remodeling, osteophyte formation, and sclerosis as coupled bone changes during OA progression. Evidence source is OTHER because this is a review article.
"OA is characterised by changes in the anatomy of load-bearing joints that lead to degradation of articular cartilage, inflammation of the synovium (synovitis), changes to subchondral bone and growth of new bone and cartilage (osteophytes) at the joint edge"
Lists cartilage degradation, subchondral bone changes, and osteophyte growth as the conserved structural hallmarks of OA. Evidence source is OTHER (review).
Joint Cartilage Degradation with Pain and Functional Impairment
consequence
The convergent endpoint is osteoarthritis itself: degradation of articular cartilage with whole-joint structural change producing chronic joint pain, stiffness, and progressive functional impairment and disability. OA pain is nociceptive but increasingly recognized as a complex condition involving local inflammation across joint structures and peripheral/central sensitization, and it is the dominant cause of the disability and socioeconomic burden of the disease.
Show evidence (3 references)
"Pain is an ubiquitous symptom in osteoarticular diseases, occurring much more commonly than stiffness or disability."
Establishes pain as the defining clinical symptom of the OA endpoint. Evidence source is OTHER because this is a review article.
"creating a huge burden related to disability and health care costs"
Documents the disability and healthcare burden that defines the functional impairment of the OA consequence node. Evidence source is OTHER (review).
"Osteoarthritis (OA) is the most common form of arthritic disease, and a major cause of disability and impaired quality of life in the elderly."
Frames OA as a leading cause of disability and impaired quality of life, the clinical consequence of the cartilage-degradation cascade. Evidence source is OTHER (review).